Centenara Labs AG
PrivateLast Round
Series B
Sep 11, 2023
Total Funding Raised
$75M
Company Overview
Centenara Labs AG is a biotechnology company that operates an integrated platform to develop therapies and fund startups focused on healthy aging and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centenara Labs AG Comparables
Compare Centenara Labs AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Endogena Therapeutics | 89% | |
| Cambrian Bio | 86% | |
| Juvenescence | 82% | |
Centenara Labs AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 11, 2023 |
Centenara Labs AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalio Capital Management | Series B |
| Coeli Asset Management | Series A |
| Apeiron Investment Group | Series B |
| Mubadala Capital | Series B |
Centenara Labs AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Centenara Labs AG's valuation, stock price, and market status.